At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 105 enrolled
Drug / intervention
Ocular geldrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase I/II, Randomized, Placebo-controlled, Double-masked, Efficacy, Safety and Local Tolerability Study of Chloroprocaine 3% Gel Eye Drops in Healthy Volunteers
In Brief
A Phase 2 clinical trial evaluating Ocular gel for Healthy Subjects. Completed, enrolled 105 participants across 1 site.
Detailed Summary
The study evaluate the efficacy, safety and local tolerability of Chloroprocaine 3% ophthalmic gel as compared to matching placebo in healthy subjects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Subjects
CountriesSwitzerland
Collaborators--
Timeline
Phase 2CompletedFinished
202120222023202420252026
Enrollment StartJun 2020
Primary CompletionOct 2020
Study CompletionOct 2020
First PostedMar 2021
TodayJul 2026
First PostedMar 3, 2021
Enrollment StartJun 16, 2020
Primary CompletionOct 13, 2020
Study CompletionOct 20, 2020
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 5.3 years ago
Interventions
Ocular geldrug
3 drops instilled in the right eye